PentaBind

Unlocking new aptamer therapeutics with generative AI

  • Biotech
Therapeutics

Member

Active

Status

2021

Founded

Development stage

  • EngBio1
    Accelerate

PentaBind is designing high performance, programmable aptamers as therapeutic delivery vehicles and active ingredients. It uses generative AI models, supported by wet-laboratory data generation processes, to help produce aptamer drugs that are easy to design, highly selective and ‘invisible’ to the immune system. Its platform enables applications across advanced therapeutics, biomanufacturing and continuous monitoring (for wearables and women's health).

Founding team

Key contacts